Bandhan Healthcare Fund - Direct Plan - Growth
Bandhan AMC Limited · Direct Plan · Growth
Fund overview
0.50% on or before 30D, Nil after 30D
Returns & rankings
| Period | Fund Returns | Category Avg. | Rank | VS Category |
|---|---|---|---|---|
| … | ||||
Green = fund outperformed the category average for that period; red = underperformed. Periods under 1 year always show absolute (non-annualised) returns. Past performance does not guarantee future returns.
Return calculator
One-time investment
₹1,000
| Over the past | Total investment | Would've become | Returns |
|---|---|---|---|
| 1 Year | ₹1,000 | ₹1,057 | +57 |
| 3 Years | ₹1,000 | ₹1,182 | +182 |
| 5 Years | ₹1,000 | ₹1,322 | +322 |
Calculated using the fund's annualised return since inception (5.7% p.a.) as period-wise historical returns aren't available in the current feed. Actual returns fluctuate and are not guaranteed. Mutual fund investments are subject to market risks.
Holdings
35 securitiesTop 10 holdings make up 50.5% of the portfolio.
| Security | Sector | Market Cap | Weight |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Pharmaceuticals & Biotechnology | Large Cap | 9.74% |
| Triparty Repo TRP_011026 | Cash/Deposits/Margins/Treps/Repo/Swaps | — | 6.72% |
| Cipla Ltd | Pharmaceuticals & Biotechnology | Large Cap | 6.18% |
| Apollo Hospitals Enterprises Ltd | Healthcare Services | Large Cap | 5.75% |
| Max Healthcare Institute Ltd | Healthcare Services | Mid Cap | 5.27% |
| Lupin Ltd | Pharmaceuticals & Biotechnology | Mid Cap | 4.35% |
| Divi'S Laboratories Ltd | Pharmaceuticals & Biotechnology | Large Cap | 4.27% |
| Shilpa Medicare Ltd | Pharmaceuticals & Biotechnology | Small Cap | 4.17% |
| Aurobindo Pharma Ltd | Pharmaceuticals & Biotechnology | Mid Cap | 4.10% |
| Dr. Reddys Laboratories Ltd | Pharmaceuticals & Biotechnology | Mid Cap | 3.78% |
Portfolio Allocation
Equity / Debt / Cash
Total Value
₹327 Cr
Market Cap Split
Total Value
100%
Equity sector allocation
Total Value
₹305 Cr
Exit load, stamp duty & tax
28-Nov-25
0.50% on or before 30D, Nil after 30D
0.005% (from July 1st, 2020)
Taxation depends on the fund category and holding period. Consult the scheme document or a tax advisor for details.
Risk & Performance Ratios (1Y)
| Standard Deviation | -- |
| Beta | -- |
| Sharpe Ratio | -- |
| Sortino Ratio | -- |
| Treynor Ratio | -- |
| Jensen's Alpha | -- |
| Information Ratio | -- |
| R-Squared | -- |
| Max Drawdown | -- |
| Upside Capture | -- |
| Downside Capture | -- |
Fund management
Scheme Details
Investment objective
The Scheme Seeks To Generate Long-Term Capital Appreciation By Investing Predominantly In Equity And Equity-Related Instruments Of Companies Engaged In Healthcare, Pharma And Allied Sectors.
Fund house
Bandhan AMC Limited
Frequently asked questions
What is the NAV of Bandhan Healthcare Fund - Direct Plan - Growth?
The NAV of Bandhan Healthcare Fund - Direct Plan - Growth is ₹10.52 as of 21 Oct 2026. NAV is updated at the end of every trading day.
How much expense ratio is charged by Bandhan Healthcare Fund - Direct Plan - Growth?
The expense ratio charged by Bandhan Healthcare Fund - Direct Plan - Growth is 1.31%.
What is the Min. SIP of Bandhan Healthcare Fund - Direct Plan - Growth?
The minimum SIP investment in Bandhan Healthcare Fund - Direct Plan - Growth is ₹100 per month.
What is the Min. Lumpsum of Bandhan Healthcare Fund - Direct Plan - Growth?
The minimum lumpsum investment in Bandhan Healthcare Fund - Direct Plan - Growth is ₹1,000.
What is the Exit Load of Bandhan Healthcare Fund - Direct Plan - Growth?
The exit load for Bandhan Healthcare Fund - Direct Plan - Growth is: 0.50% on or before 30D, Nil after 30D
.svg){kind=small}